The DOI matches its Crossref record; 74 of the 77 references it cites were found in a registry or an index.
Crystal Structure of Cas9 in Complex with Guide RNA and Target DNA
Open accessAbstract
The CRISPR-associated endonuclease Cas9 can be targeted to specific genomic loci by single guide RNAs (sgRNAs). Here, we report the crystal structure of Streptococcus pyogenes Cas9 in complex with sgRNA and its target DNA at 2.5 Å resolution. The structure revealed a bilobed architecture composed of target recognition and nuclease lobes, accommodating the sgRNA:DNA heteroduplex in a positively charged groove at their interface. Whereas the recognition lobe is essential for binding sgRNA and DNA, the nuclease lobe contains the HNH and RuvC nuclease domains, which are properly positioned for cleavage of the complementary and noncomplementary strands of the target DNA, respectively. The nuclease lobe also contains a carboxyl-terminal domain responsible for the interaction with the protospacer adjacent motif (PAM). This high-resolution structure and accompanying functional analyses have revealed the molecular mechanism of RNA-guided DNA targeting by Cas9, thus paving the way for the rational design of new, versatile genome-editing technologies.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source doesn’t support the claim as written.
In the citing paper
“Upon binding of Streptococcus pyogenes Cas9 (SpCas9) to the target site, a stable strand separation is maintained through two kinds of interactions: the binding of gRNA to the target strand, and a positively-charged groove resulting from the unspecific interaction of both HNH and RuvC domains with the negatively-charged non-target strand [36].”
From CRISPR-Cas: Converting A Bacterial Defence Mechanism into A State-of-the-Art Genetic Manipulation Tool (2019) · cites this paper as [36]
Checked by a reasoning model — may be wrong.
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“tracrRNA is complementary to the repeat sequence and contains 3 stem-loop hairpin structures [35,36].”
From CRISPR-Cas: Converting A Bacterial Defence Mechanism into A State-of-the-Art Genetic Manipulation Tool (2019) · cites this paper as [36]
The cited source says what the claim attributes to it.
In the citing paper
“The structure that came out of the laboratory of Jennifer Doudna was of an apo-protein (PDBe ID 4cmp, PDBe DOI: 10.2210/pdb4cmp/pdb), while the research group of Osamu Nureki (University of Tokyo, Japan) succeeded in crystallising the protein in a complex with a “guide”-RNA and “target”-DNA (PDBe ID 4oo8, PDBe DOI: 10.2210/pdb4oo8/pdb).”
From CRISPR–Cas9: A History of Its Discovery and Ethical Considerations of Its Use in Genome Editing (2022) · cites this paper as [40]
The cited source says what the claim attributes to it.
In the citing paper
“The key structures of the nuclease lobe of SpCas9 are 2 domains: HNH and RuvC, each of them cleaves one of the target DNA strands.”
From CRISPR–Cas9: A History of Its Discovery and Ethical Considerations of Its Use in Genome Editing (2022) · cites this paper as [40]
The cited source says what the claim attributes to it.
In the citing paper
“Crystal structures revealed that the Cas9 protein is spatially divided into 2 lobes: a target recognition lobe and a nuclease lobe, with the guide RNA and target DNA occupying the positively charged groove at their interface.”
From CRISPR–Cas9: A History of Its Discovery and Ethical Considerations of Its Use in Genome Editing (2022) · cites this paper as [40]
The check wasn’t confident either way, so it gives no verdict — never disputed.
In the citing paper
“For example, SpCas9-NG shows reduced editing efficiency on 5′-NGC-3′ PAM targets and tends to increase off-target activity (Nishimasu et al., 2014).”
From Emerging applications of gene editing technologies for the development of climate-resilient crops (2025) · cites this paper as Nishimasu et al., 2014
Experimental — accuracy not yet measuredIn the citing paper
“Attempts to obtain detailed information about the structure of this protein resulted in the first two crystallographic studies being published almost simultaneously: in February 2014 two crystal structures of Cas9 appeared in the database PDBe (“Protein Data Bank in Europe”), and the accompanying articles were published in the journals Nature and Cell [39, 40].”
From CRISPR–Cas9: A History of Its Discovery and Ethical Considerations of Its Use in Genome Editing (2022) · cites this paper as [40]
In the citing paper
“These, as well as many subsequent studies, used the Cas9 protein from S. pyogenes, SpCas9, which consists of 1368 amino acids and is a multidomain and multifunctional endonuclease.”
From CRISPR–Cas9: A History of Its Discovery and Ethical Considerations of Its Use in Genome Editing (2022) · cites this paper as [40]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Sheldrick, G. M. (2007) · Acta Crystallographica Section A Foundations of Crystallography · doi:10.1107/s0108767307043930 · Cited by 88,113
Gapped BLAST and PSI-BLAST: a new generation of protein database search programs
Altschul, S. (1997) · Nucleic Acids Research · doi:10.1093/nar/25.17.3389 · Cited by 73,302
Coot : model-building tools for molecular graphics
Emsley, P., & Cowtan, K. (2004) · Acta Crystallographica Section D Biological Crystallography · doi:10.1107/s0907444904019158 · Cited by 30,571
A Programmable Dual-RNA–Guided DNA Endonuclease in Adaptive Bacterial Immunity
Jinek, M., Chylinski, K., Fonfara, I., Hauer, M., Doudna, J. A., & Charpentier, E. (2012) · Science · doi:10.1126/science.1225829 · Cited by 17,116
Kabsch, W. (2010) · Acta Crystallographica Section D Biological Crystallography · doi:10.1107/s0907444909047337 · Cited by 16,463
Multiplex Genome Engineering Using CRISPR/Cas Systems
Cong, L., Ran, F. A., Cox, D., Lin, S., Barretto, R., Habib, N., Hsu, P. D., Wu, X., Jiang, W., Marraffini, L. A., et al. (2013) · Science · doi:10.1126/science.1231143 · Cited by 15,339
Self-citationRNA-Guided Human Genome Engineering via Cas9
Mali, P., Yang, L., Esvelt, K. M., Aach, J., Guell, M., DiCarlo, J. E., Norville, J. E., & Church, G. M. (2013) · Science · doi:10.1126/science.1232033 · Cited by 9,210
PHENIX: a comprehensive Python-based system for macromolecular structure solution
Adams, P. D., Afonine, P. V., Bunkòczi, G., Chen, V. B., Davis, I., Echols, N., Headd, J. J., Hung, L., Kapral, G. J., Grosse‐Kunstleve, R. W., et al. (2012) · International Tables for Crystallography · doi:10.1107/97809553602060000865 · Cited by 7,334
CRISPR Provides Acquired Resistance Against Viruses in Prokaryotes
Barrangou, R., Fremaux, C., Deveau, H., Richards, M., Boyaval, P., Moineau, S., Romero, D. A., & Horvath, P. (2007) · Science · doi:10.1126/science.1138140 · Cited by 5,947
Genome-scale CRISPR-Cas9 knockout screening in human cells
Shalem, O., Sanjana, N. E., Hartenian, E., Shi, X., Scott, D. A., Mikkelsen, T. S., Heckl, D., Ebert, B. L., Root, D. E., Doench, J. G., et al. (2014) · Science · doi:10.1126/science.1247005 · Cited by 5,234
Self-citation
Flagged first, then by citations
3 of the 77 references couldn’t be matched to a known paper.
Research works printed but not linked: 1
- Cowtan, 1994, ‘dm’: An automated procedure for phase improvement by density modification, Joint CCP4 and ESF-EACBM Newsletter on Protein Crystallography, 31, 34
Cited by
Sorted by citations
Items 401–500 of 1,002
Casalino, L., Nierzwicki, Ł., Jínek, M., & Palermo, G. (2020) · ACS Catalysis · doi:10.1021/acscatal.0c03566 · Cited by 105
Enabling functional genomics with genome engineeringPreprint
Hilton, I. B., & Gersbach, C. A. (2015) · Genome Research · doi:10.1101/gr.190124.115 · Cited by 106
Structural basis for the altered PAM recognition by engineered CRISPR-Cpf1
Nishimasu, H., Yamano, T., Gao, L., Zhang, F., Ishitani, R., & Nureki, O. (2017) · Molecular Cell · doi:10.1016/j.molcel.2017.04.019 · Cited by 102
Decoding non-random mutational signatures at Cas9 targeted sites
Taheri‐Ghahfarokhi, A., Taylor, B., Nitsch, R., Lundin, A., Cavallo, A.-L., Madeyski-Bengtson, K., Karlsson, F. H., Clausen, M., Hicks, R., Mayr, L. M., et al. (2018) · Nucleic Acids Research · doi:10.1093/nar/gky653 · Cited by 111
Harnessing CRISPR-Cas9 immunity for genetic engineering
Charpentier, E., & Marraffini, L. A. (2014) · Current Opinion in Microbiology · doi:10.1016/j.mib.2014.07.001 · Cited by 107
An overview and metanalysis of machine and deep learning-based CRISPR gRNA design tools
Wang, J., Zhang, X., Cheng, L., & Luo, Y. (2019) · RNA Biology · doi:10.1080/15476286.2019.1669406 · Cited by 106
Principles of Genetic Engineering
Lanigan, T. M., Kopera, H. C., & Saunders, T. L. (2020) · Genes · doi:10.3390/genes11030291 · Cited by 114
CRISPR/Cas9 gRNA activity depends on free energy changes and on the target PAM context
Corsi, G. I., Qu, K., Alkan, F., Pan, X., Luo, Y., & Gorodkin, J. (2022) · Nature Communications · doi:10.1038/s41467-022-30515-0 · Cited by 104
Making designer mutants in model organisms
Peng, Y., Clark, K. J., Campbell, J. M., Panetta, M. R., Guo, Y., & Ekker, S. C. (2014) · Development · doi:10.1242/dev.102186 · Cited by 103
Transforming plant biology and breeding with CRISPR /Cas9, Cas12 and Cas13
Schindele, P., Wolter, F., & Puchta, H. (2018) · FEBS Letters · doi:10.1002/1873-3468.13073 · Cited by 110
The Rise of the CRISPR/Cpf1 System for Efficient Genome Editing in Plants
Alok, A., Sandhya, D., Jogam, P., Rodrigues, V. L., Bhati, K. K., Sharma, H., & Kumar, J. (2020) · Frontiers in Plant Science · doi:10.3389/fpls.2020.00264 · Cited by 99
CRISPR-based gene editing technology and its application in microbial engineering
Wei, J., & Li, Y. (2023) · Engineering Microbiology · doi:10.1016/j.engmic.2023.100101 · Cited by 106
Rapidly inducible Cas9 and DSB-ddPCR to probe editing kinetics
Rose, J. C., Stephany, J. J., Valente, W. J., Trevillian, B. M., Dang, H. V., Bielas, J. H., Maly, D. J., & Fowler, D. M. (2017) · Nature Methods · doi:10.1038/nmeth.4368 · Cited by 101
Kato-Inui, T., Takahashi, G., Hsu, S., & Miyaoka, Y. (2018) · Nucleic Acids Research · doi:10.1093/nar/gky264 · Cited by 101
Genetic glycoengineering in mammalian cells
Narimatsu, Y., Büll, C., Chen, Y., Wandall, H. H., Yang, Z., & Clausen, H. (2021) · Journal of Biological Chemistry · doi:10.1016/j.jbc.2021.100448 · Cited by 103
Wang, L., Shao, Y., Guan, Y., Li, L., Wu, L., Chen, F., Liu, M., Chen, H., Ma, Y., Ma, X., et al. (2015) · Scientific Reports · doi:10.1038/srep17517 · Cited by 97
Structural Basis for the Inhibition of CRISPR-Cas12a by Anti-CRISPR Proteins
Zhang, H., Li, Z., Daczkowski, C. M., Gabel, C. A., Mesecar, A. D., & Chang, L. (2019) · Cell Host & Microbe · doi:10.1016/j.chom.2019.05.004 · Cited by 99
Genome Editing Using Cas9 Nickases
Trevino, A. E., & Zhang, F. (2014) · Methods in enzymology on CD-ROM/Methods in enzymology · doi:10.1016/b978-0-12-801185-0.00008-8 · Cited by 106
CRISPR/Cas9: An RNA‐guided highly precise synthetic tool for plant genome editing
Demirci, Y., Zhang, B., & Ünver, T. (2017) · Journal of Cellular Physiology · doi:10.1002/jcp.25970 · Cited by 103
A split CRISPR–Cpf1 platform for inducible genome editing and gene activation
Nihongaki, Y., Otabe, T., Ueda, Y., & Sato, M. (2019) · Nature Chemical Biology · doi:10.1038/s41589-019-0338-y · Cited by 98
Prime editing with genuine Cas9 nickases minimizes unwanted indels
Lee, J., Lim, K., Kim, A., Mok, Y. G., Chung, E., Cho, S.-I., Lee, J. M., & Kim, J. (2023) · Nature Communications · doi:10.1038/s41467-023-37507-8 · Cited by 103
Xu, L., Zhao, L., Gao, Y., Xu, J., & Han, R. (2016) · Nucleic Acids Research · doi:10.1093/nar/gkw1048 · Cited by 91
Structures and Strategies of Anti-CRISPR-Mediated Immune Suppression
Wiegand, T., Karambelkar, S., Bondy‐Denomy, J., & Wiedenheft, B. (2020) · Annual Review of Microbiology · doi:10.1146/annurev-micro-020518-120107 · Cited by 97
CRISPR/Cas System and Factors Affecting Its Precision and Efficiency
Javaid, N., & Choi, S. (2021) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2021.761709 · Cited by 106
A universal deep-learning model for zinc finger design enables transcription factor reprogramming
Ichikawa, D. M., Abdin, O., Alerasool, N., Kogenaru, M., Mueller, A. L., Wen, H., Giganti, D. O., Goldberg, G. W., Adams, S., Spencer, J. M., et al. (2023) · Nature Biotechnology · doi:10.1038/s41587-022-01624-4 · Cited by 101
Genetic screens and functional genomics using CRISPR /Cas9 technology
Hartenian, E., & Doench, J. G. (2015) · FEBS Journal · doi:10.1111/febs.13248 · Cited by 100
Li, M., Yu, J., Tilgner, K., Ong, S. H., Koike-Yusa, H., & Yusa, K. (2018) · Cell Reports · doi:10.1016/j.celrep.2018.06.027 · Cited by 96
CRISPR/Cas9 – An evolving biological tool kit for cancer biology and oncology
Tian, X., Gu, T., Patel, S., Bode, A. M., Lee, M., & Dong, Z. (2019) · npj Precision Oncology · doi:10.1038/s41698-019-0080-7 · Cited by 105
Guide RNA modification as a way to improve CRISPR/Cas9-based genome-editing systems
Filippova, J. A., Matveeva, A. M., Zhuravlev, E. S., & Stepanov, G. A. (2019) · Biochimie · doi:10.1016/j.biochi.2019.09.003 · Cited by 98
Conditional control of RNA-guided nucleic acid cleavage and gene editing
Wang, S., Wu, L., Huang, H., Xiong, W., Liu, J., Wei, L., Yin, P., Tian, T., & Zhou, X. (2020) · Nature Communications · doi:10.1038/s41467-019-13765-3 · Cited by 97
Tadić, V., Josipović, G., Zoldoš, V., & Vojta, A. (2019) · Methods · doi:10.1016/j.ymeth.2019.05.003 · Cited by 99
Structural basis for RNA-guided DNA cleavage by IscB-ωRNA and mechanistic comparison with Cas9
Schuler, G. A., Hu, C., & Ke, A. (2022) · Science · doi:10.1126/science.abq7220 · Cited by 95
Ahmadi, S. E., Soleymani, M., Shahriyary, F., Amirzargar, M. R., Mahya, O., Fattahi, D., & Safa, M. (2023) · Cancer Gene Therapy · doi:10.1038/s41417-023-00597-z · Cited by 97
Prime editing using CRISPR-Cas12a and circular RNAs in human cells
Liang, R., He, Z., Zhao, K. T., Zhu, H., Hu, J., Liu, G., Gao, Q., Liu, M., Zhang, R., Qiu, J., et al. (2024) · Nature Biotechnology · doi:10.1038/s41587-023-02095-x · Cited by 100
Mechanisms of precise genome editing using oligonucleotide donorsPreprint
Kan, Y., Ruis, B. L., Takasugi, T., & Hendrickson, E. A. (2017) · Genome Research · doi:10.1101/gr.214775.116 · Cited by 92
Molecular insights into DNA interference by CRISPR-associated nuclease-helicase Cas3
Gong, B., Shin, M., Sun, J., Jung, C., Bolt, E. L., John van der, O. O. S. T., & Kim, J. (2014) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1410806111 · Cited by 100
Masi, C. D., Spitalieri, P., Murdocca, M., Novelli, G., & Sangiuolo, F. C. (2020) · Human Genomics · doi:10.1186/s40246-020-00276-2 · Cited by 108
Structures and mechanisms of CRISPR RNA-guided effector nucleases
Nishimasu, H., & Nureki, O. (2016) · Current Opinion in Structural Biology · doi:10.1016/j.sbi.2016.11.013 · Cited by 99
Two Distinct DNA Binding Modes Guide Dual Roles of a CRISPR-Cas Protein Complex
Blosser, T. R., Loeff, L., Westra, E. R., Vlot, M., Künne, T., Sobota, M., Dekker, C., Brouns, S. J. J., & Joo, C. (2015) · Molecular Cell · doi:10.1016/j.molcel.2015.01.028 · Cited by 92
Chemical and Biophysical Modulation of Cas9 for Tunable Genome Engineering
Nuñez, J. K., Harrington, L. B., & Doudna, J. A. (2016) · ACS Chemical Biology · doi:10.1021/acschembio.5b01019 · Cited by 92
Singh, V., Gohil, N., Ramirez-Garcia, R., Braddick, D., & Fofié, C. K. (2017) · Journal of Cellular Biochemistry · doi:10.1002/jcb.26165 · Cited by 92
Zhou, Y., Lin, L., Wang, H., Zhang, Z., Zhou, J. Z., & Jiao, N. (2020) · Communications Biology · doi:10.1038/s42003-020-0824-5 · Cited by 92
CRISPR-Cas systems: From gene scissors to programmable biosensors
Zhang, Y., Wu, Y., Wu, Y., Chang, Y., & Liu, M. (2021) · TrAC Trends in Analytical Chemistry · doi:10.1016/j.trac.2021.116210 · Cited by 93
Efficient target cleavage by Type V Cas12a effectors programmed with split CRISPR RNA
Shebanova, R., Nikitchina, N., Shebanov, N., Mekler, V. M., Kuznedelov, K. D., Ulashchik, E. A., Vasilev, R. A., Sharko, O. L., Shmanai, V. V., Tarassov, I., et al. (2021) · Nucleic Acids Research · doi:10.1093/nar/gkab1227 · Cited by 92
John van der, O. O. S. T., & Patinios, C. (2023) · Trends in biotechnology · doi:10.1016/j.tibtech.2022.12.022 · Cited by 102
Discovery of Diverse CRISPR-Cas Systems and Expansion of the Genome Engineering Toolbox
Koonin, E. V., Gootenberg, J. S., & Abudayyeh, O. O. (2023) · Biochemistry · doi:10.1021/acs.biochem.3c00159 · Cited by 95
Targeting miRNA by CRISPR/Cas in cancer: advantages and challenges
Hussen, B. M., Rasul, M. F., Abdullah, S. R., Hidayat, H. J., Faraj, G. S. H., Ali, F. A., Salihi, A. B., Baniahmad, A., Ghafouri‐Fard, S., Rahman, M., et al. (2023) · Military Medical Research · doi:10.1186/s40779-023-00468-6 · Cited by 106
Versatility of chemically synthesized guide RNAs for CRISPR-Cas9 genome editing
Kelley, M. L., Strezoska, Ž., He, K., Vermeulen, A., & Smith, A. V. B. (2016) · Journal of Biotechnology · doi:10.1016/j.jbiotec.2016.06.011 · Cited by 89
Transcription control engineering and applications in synthetic biology
Engstrom, M. D., & Pfleger, B. F. (2017) · Synthetic and Systems Biotechnology · doi:10.1016/j.synbio.2017.09.003 · Cited by 96
Comprehensive Mechanism of Gene Silencing and Its Role in Plant Growth and Development
El‐Sappah, A. H., Yan, K., Huang, Q., Islam, M. M., Li, Q., Wang, Y., Khan, M. S., Xianming, Z., Mir, R. R., Li, J., et al. (2021) · Frontiers in Plant Science · doi:10.3389/fpls.2021.705249 · Cited by 95
CRISPR/Cas9 Landscape: Current State and Future Perspectives
Tyumentsev, A. I., Tyumentsev, A. I., & Акимкин, В. Г. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms242216077 · Cited by 98
Kondo, T., Ando, M., Nagai, N., Tomisato, W., Srirat, T., Liu, B., Mise‐Omata, S., Ikeda, M., Chikuma, S., Nishimasu, H., et al. (2019) · Cancer Research · doi:10.1158/0008-5472.can-19-1196 · Cited by 92
Chen, S., Wang, R., Peng, S., Xie, S., Lei, C., Huang, Y., & Nie, Z. (2022) · Chemical Science · doi:10.1039/d1sc05558e · Cited by 89
Effective gene editing by high-fidelity base editor 2 in mouse zygotes
Liang, P., Sun, H., Sun, Y., Zhang, X., Xie, X., Zhang, J., Zhang, Z., Chen, Y., Ding, C., Xiong, Y., et al. (2017) · Protein & Cell · doi:10.1007/s13238-017-0418-2 · Cited by 91
Biomaterials as vectors for the delivery of CRISPR–Cas9
Eoh, J. H., & Gu, L. (2019) · Biomaterials Science · doi:10.1039/c8bm01310a · Cited by 92
Hazafa, A., Mumtaz, M., Farooq, M. F., Bilal, S., Chaudhry, S. N., Firdous, M., Naeem, H., Ullah, M. O., Yameen, M., Mukhtiar, M., et al. (2020) · Life Sciences · doi:10.1016/j.lfs.2020.118525 · Cited by 98
A natural single-guide RNA repurposes Cas9 to autoregulate CRISPR-Cas expression
Workman, R. E., Pammi, T., Nguyen, B. T. K., Graeff, L. W., Smith, E. L., Sebald, S. M., Stoltzfus, M. J., Euler, C. W., & Modell, J. W. (2021) · Cell · doi:10.1016/j.cell.2020.12.017 · Cited by 82
CRISPR–Cas9 bends and twists DNA to read its sequence
Cofsky, J. C., Soczek, K. M., Knott, G. J., Nogales, E., & Doudna, J. A. (2022) · Nature Structural & Molecular Biology · doi:10.1038/s41594-022-00756-0 · Cited by 91
Mekler, V. M., Станиславович, М. Л., Semenova, E., Kuznedelov, K. D., & Severinov, K. (2016) · Nucleic Acids Research · doi:10.1093/nar/gkw138 · Cited by 93
CRISPR/Cas9 in plants: at play in the genome and at work for crop improvement
Hussain, B., Lucas, S. J., & Budak, H. (2018) · Briefings in Functional Genomics · doi:10.1093/bfgp/ely016 · Cited by 89
Dronina, J., Samukaitė-Bubnienė, U., & Ramanavičius, A. (2020) · Biosensors and Bioelectronics · doi:10.1016/j.bios.2020.112867 · Cited by 88
Fei, H., Li, Y., Liu, Y., Wei, J., Chen, A. A., & Gao, C. (2025) · Cell · doi:10.1016/j.cell.2025.06.014 · Cited by 96
Beyond Native Cas9: Manipulating Genomic Information and Function
Mitsunobu, H., Teramoto, J., Nishida, K., & Kondo, A. (2017) · Trends in biotechnology · doi:10.1016/j.tibtech.2017.06.004 · Cited by 87
CRISPR-Cas based antiviral strategies against HIV-1
Wang, G., Zhao, N., Berkhout, B., & Das, A. T. (2017) · Virus Research · doi:10.1016/j.virusres.2017.07.020 · Cited by 86
Application of the CRISPR/Cas9 System to Drug Resistance in Breast Cancer
Chen, Y., & Zhang, Y. (2018) · Advanced Science · doi:10.1002/advs.201700964 · Cited by 91
Wu, H., He, J., Zhang, F., Ping, J. F., & Wu, J. F. (2019) · Analytica Chimica Acta · doi:10.1016/j.aca.2019.10.042 · Cited by 87
Sapozhnikov, D. M., & Szyf, M. (2021) · Nature Communications · doi:10.1038/s41467-021-25991-9 · Cited by 83
Trans-nuclease activity of Cas9 activated by DNA or RNA target binding
Chen, J., Chen, Y., Huang, L., Lin, X., Chen, H., Xiang, W., & Liu, L. (2024) · Nature Biotechnology · doi:10.1038/s41587-024-02255-7 · Cited by 87
Cas9 Targeting and the CRISPR Revolution
Barrangou, R. (2014) · Science · doi:10.1126/science.1252964 · Cited by 92
Chemically Modified Cpf1-CRISPR RNAs Mediate Efficient Genome Editing in Mammalian Cells
McMahon, M. A., Prakash, T. P., Cleveland, D. W., Bennett, C. F., & Rahdar, M. (2018) · Molecular Therapy · doi:10.1016/j.ymthe.2018.02.031 · Cited by 87
Guide RNA engineering for versatile Cas9 functionality
Nowak, C. M., Lawson, S., Zerez, M., & Bleris, L. G. (2016) · Nucleic Acids Research · doi:10.1093/nar/gkw908 · Cited by 83
Paired D10A Cas9 nickases are sometimes more efficient than individual nucleases for gene disruption
Gopalappa, R., Suresh, B., Ramakrishna, S., & Kim, S. (2018) · Nucleic Acids Research · doi:10.1093/nar/gky222 · Cited by 86
Molecular architectures and mechanisms of Class 2 CRISPR-associated nucleases
Garcia‐Doval, C., & Jínek, M. (2017) · Current Opinion in Structural Biology · doi:10.1016/j.sbi.2017.10.015 · Cited by 85
Dubey, A. K., Gupta, V. K., Kujawska, M., Orive, G., Kim, N., Li, C.-Z., Mishra, Y. K., & Kaushik, A. K. (2022) · Journal of nanostructure in chemistry · doi:10.1007/s40097-022-00472-7 · Cited by 88
Zhu, Y. (2022) · BioMed Research International · doi:10.1155/2022/9978571 · Cited by 103
Peroxisome biogenesis initiated by protein phase separation
Ravindran, R., Bacellar, I. O. L., Castellanos-Girouard, X., Wahba, H. M., Zhang, Z., Omichinski, J. G., Kisley, L., & Michnick, S. W. (2023) · Nature · doi:10.1038/s41586-023-06044-1 · Cited by 88
Bacterial CRISPR: accomplishments and prospects
Peters, J. M., Silvis, M. R., Zhao, D., Hawkins, J. S., Gross, C. A., & Qi, L. S. (2015) · Current Opinion in Microbiology · doi:10.1016/j.mib.2015.08.007 · Cited by 88
MicroRNA-focused CRISPR-Cas9 library screen reveals fitness-associated miRNAs
Kurata, J. S., & Lin, R.-J. (2018) · RNA · doi:10.1261/rna.066282.118 · Cited by 82
Qian, J., Huang, D., Ni, D., Zhao, J., Shi, Z., Fang, M., & Xu, Z. (2021) · Food Control · doi:10.1016/j.foodcont.2021.108485 · Cited by 84
Chemical Modifications of CRISPR RNAs to Improve Gene-Editing Activity and Specificity
Rozners, E. (2022) · Journal of the American Chemical Society · doi:10.1021/jacs.2c02633 · Cited by 89
Rapid Evolution of Manifold CRISPR Systems for Plant Genome Editing
Lowder, L. G., Malzahn, A. A., & Qi, Y. (2016) · Frontiers in Plant Science · doi:10.3389/fpls.2016.01683 · Cited by 88
Towards personalised allele-specific CRISPR gene editing to treat autosomal dominant disorders
Christie, K. A., Courtney, D., DeDionisio, L., Chao-Shern, C., Majumdar, S. D., Mairs, L., Nesbit, M. A., & Moore, T. (2017) · Scientific Reports · doi:10.1038/s41598-017-16279-4 · Cited by 83
Temperature-Responsive Competitive Inhibition of CRISPR-Cas9
Jiang, F., Liu, J., Osuna, B. A., Xu, M. Y., Berry, J. D., Rauch, B. J., Nogales, E., Bondy‐Denomy, J., & Doudna, J. A. (2018) · Molecular Cell · doi:10.1016/j.molcel.2018.11.016 · Cited by 83
Establishment and application of a CRISPR–Cas12a assisted genome-editing system in Zymomonas mobilis
Shen, W., Zhang, J., Geng, B., Qiu, M., Hu, M., Yang, Q., Bao, W., Xiao, Y., Zheng, Y., Peng, W., et al. (2019) · Microbial Cell Factories · doi:10.1186/s12934-019-1219-5 · Cited by 83
Challenges and Perspectives in Homology-Directed Gene Targeting in Monocot Plants
Vu, T. V., Sung, Y. W., Kim, J., Tran, M. T., Tran, M. T., & Kim, J. (2019) · Rice · doi:10.1186/s12284-019-0355-1 · Cited by 83
Chen, P., Zhou, J., Wan, Y., Liu, H., Li, Y., Liu, Z., Wang, H., Lei, J., Zhao, K., Zhang, Y., et al. (2020) · Genome biology · doi:10.1186/s13059-020-01989-2 · Cited by 86
Rationally Designed Base Editors for Precise Editing of the Sickle Cell Disease Mutation
Chu, S. H., Packer, M. S., Rees, H. A., Lam, D. K., Yu, Y., Marshall, J., Cheng, L.-I., Lam, D., Olins, J., Ran, F. A., et al. (2021) · The CRISPR Journal · doi:10.1089/crispr.2020.0144 · Cited by 79
Endogenous Fluorescence Tagging by CRISPR
Bukhari, H., & Müller, T. (2019) · Trends in Cell Biology · doi:10.1016/j.tcb.2019.08.004 · Cited by 82
Liu, Q., He, D., & Xie, L. (2019) · PLoS Computational Biology · doi:10.1371/journal.pcbi.1007480 · Cited by 86
Allen, D. G., Rosenberg, M., & Hendel, A. (2021) · Frontiers in Genome Editing · doi:10.3389/fgeed.2020.617910 · Cited by 89
The tracrRNA in CRISPR Biology and Technologies
Liao, C., & Beisel, C. L. (2021) · Annual Review of Genetics · doi:10.1146/annurev-genet-071719-022559 · Cited by 91
Metagenomic discovery of CRISPR-associated transposons
Rybarski, J. R., Hu, K., Hill, A. M., Wilke, C. O., & Finkelstein, I. J. (2021) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2112279118 · Cited by 79
Therapeutic potential of CRISPR/Cas9 gene editing in engineered T‐cell therapy
Gao, Q., Dong, X., Xu, Q., Zhu, L., Wang, F., Hou, Y., & Chao, C. (2019) · Cancer Medicine · doi:10.1002/cam4.2257 · Cited by 85
Application of CRISPR/Cas9 Technology in Cancer Treatment: A Future Direction
Rabaan, A. A., AlSaihati, H., Bukhamsin, R., Bakhrebah, M. A., Nassar, M. S., Alsaleh, A. A., Alhashem, Y. N., Bukhamseen, A. Y., Al-Ruhimy, K., Alotaibi, M. H., et al. (2023) · Current Oncology · doi:10.3390/curroncol30020152 · Cited by 89
Conformational states of Cas9-sgRNA-DNA ternary complex in the presence of magnesium
Zhu, X. Q., Clarke, R., Puppala, A. K., Chittori, S., Merk, A., Merrill, B. J., Simonović, M., & Subramaniam, S. (2019) · Worldwide Protein Data Bank · doi:10.2210/pdb6o0z/pdb · Cited by 82
Gene silencing with CRISPRi in bacteria and optimization of dCas9 expression levels
Depardieu, F., & Bikard, D. (2020) · Methods · doi:10.1016/j.ymeth.2019.07.024 · Cited by 86
Photoactivatable RNA N6‐Methyladenosine Editing with CRISPR‐Cas13
Zhao, J., Li, B., Ma, J., Jin, W., & Ma, X. (2020) · Small · doi:10.1002/smll.201907301 · Cited by 81
Brandts, J., & Ray, K. K. (2021) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2021.09.004 · Cited by 84
Multiplex base- and prime-editing with drive-and-process CRISPR arrays
Yuan, Q., & Gao, X. (2022) · Nature Communications · doi:10.1038/s41467-022-30514-1 · Cited by 85
Structural mechanism of bridge RNA-guided recombination
Hiraizumi, M., Perry, N. T., Durrant, M. G., Soma, T., Nagahata, N., Okazaki, S., Athukoralage, J. S., Isayama, Y., Pai, J. J., Pawluk, A., et al. (2024) · Nature · doi:10.1038/s41586-024-07570-2 · Cited by 84
Metadata
- Authors
- Nishimasu, H., Ran, F. A., Hsu, P. D., Konermann, S., Shehata, S. I., Dohmae, N., Ishitani, R., Zhang, F., & Nureki, O.
- Affiliations
- Japan Science and Technology Agency (JP)
- Broad Institute (US)
- RIKEN (JP)
- The University of Tokyo (JP)
- Corresponding author
- Zhang, Feng
- Nureki, Osamu
- ORCID
- Venue
- Cell
- Publisher
- Elsevier BV
- Published
- 2014-02
- Volume
- 156
- Issue
- 5
- Pages
- 935-949
- ISSN
- 0092-8674 (ISSN-L)
- PMC
- PMC4139937
- OpenAlex
- W2107959600
- Cited by
- 2,306
- References
- 77
- Citations by year
- 2026: 130 · 2025: 193 · 2024: 221 · 2023: 177 · 2022: 229 · 2021: 218 · 2020: 215 · 2019: 212 · 2018: 191 · 2017: 193 · 2016: 149 · 2015: 93 · 2014: 80
- FWCI
- 70.34
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Licence
- Locations
- Cell (publishedVersion)
- PubMed (publishedVersion)
- Europe PMC (PubMed Central) (acceptedVersion)
- PubMed Central (acceptedVersion)
- DSpace@MIT (Massachusetts Institute of Technology) (submittedVersion, cc-by-nc-nd)
- eScholarship (California Digital Library) (submittedVersion)
- PMC
- Funders
- PRESTO from the Japan Science and Technology (JST) Agency
- Drug Discovery and Informatics
- Japan Society for the Promotion of Science (JSPS)
- Core Research for Evolutional Science and Technology (CREST)
- Japan Science and Technology Agency (JST)
- NIH (5DP1-MH100706)
- Keck
- McKnight
- Poitras
- Merkin
- Vallee
- Damon Runyon
- Searle Scholars
- Klingenstein
- Simons Foundations
- Bob Metcalfe
- Jane Pauley
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › CRISPR and Genetic Engineering
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › RNA regulation and disease
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Structural Biology › Enzyme Structure and Function
- Keywords
- CRISPR/Cas12a, guide RNA, target DNA, RNA-guided DNA cleavage, protospacer adjacent motif, genome editing, crystal structure
- MeSH terms
- Amino Acid Sequence, Bacteria, DNA, Bacterial, Endonucleases, Models, Molecular, Molecular Sequence Data, RNA, Bacterial, Streptococcus pyogenes, Sequence Alignment, Protein Structure, Tertiary, Crystallography, X-Ray, RNA, Small Untranslated, CRISPR-Associated Proteins
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
